Jennison Associates LLC Rocket Pharmaceuticals, Inc. Transaction History
Jennison Associates LLC
- $162 Billion
- Q4 2024
A detailed history of Jennison Associates LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 70,304 shares of RCKT stock, worth $726,943. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,304
Previous 40,740
72.57%
Holding current value
$726,943
Previous $752,000
17.42%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RCKT
# of Institutions
218Shares Held
93.3MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$183 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$116 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$64 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$57.3 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$46.5 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $783M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...